Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Juno Therapeutics, Inc. (JUNO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K
Revenues  111.979.418.20.0
            Revenue growth  41.0%335.7%  
Cost of goods sold  0.00.00.00.0
Gross profit  111.979.418.20.0
            Gross margin  100.0%100.0%100.0% 
Selling, general and administrative   [+]108.170.757.228.2
Research and development  451.5264.3205.2204.5
EBITDA   [+]-424.1-241.4-238.1-232.4
            EBITDA margin  -379.1%-304.2%-1306.9% 
Depreciation  16.314.26.00.4
EBITA  -440.5-255.6-244.1-232.8
            EBITA margin  -393.7%-322.1%-1340.1% 
Amortization of intangibles  7.3   
EBIT   [+]-447.8-255.6-244.1-232.8
            EBIT margin  -400.3%-322.1%-1340.1% 
Interest income  8.45.91.70.1
Other income (expense), net  -3.7-6.50.2-10.7
Pre-tax income  -443.1-256.2-242.1-243.4
Income taxes  -6.0-10.7-2.80.0
            Tax rate  1.4%4.2%1.1%0.0%
Net income  -437.1-245.6-239.4-310.9
            Net margin  -390.7%-309.5%-1314.2% 
   
Basic EPS   [+]($4.10)($2.42)($2.72)($36.82)
Diluted EPS   [+]($4.10)($2.42)($2.72)($36.82)
   
Shares outstanding (basic)   [+]106.7101.588.18.4
Shares outstanding (diluted)   [+]106.7101.588.18.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy